Jeffrey Alan Jones - Dec 18, 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Chief Medical Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Dec 18, 2024
Transactions value $
-$52,851
Form type
4
Date filed
12/20/2024, 05:00 PM
Previous filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale -$52.9K -4.63K -3.9% $11.41 114K Dec 18, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.